Smartwatch based automatic detection of out-of-hospital cardiac arrest: Study rationale and protocol of the
Out-of-Hospital Cardiac Arrest
Photoplethysmography
Smartwatch
Journal
Resuscitation plus
ISSN: 2666-5204
Titre abrégé: Resusc Plus
Pays: Netherlands
ID NLM: 101774410
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
17
10
2022
revised:
18
10
2022
accepted:
21
10
2022
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
18
11
2022
Statut:
epublish
Résumé
Out-of-hospital cardiac arrest (OHCA) is a leading cause of mortality. Immediate detection and treatment are of paramount importance for survival and good quality of life. The first link in the 'chain of survival' after OHCA - the early recognition and alerting of emergency medical services - is at the same time the weakest link as it entirely depends on witnesses. About one half of OHCA cases are unwitnessed, and victims of unwitnessed OHCA have virtually no chance of survival with good neurologic outcome. Also in case of a witnessed cardiac arrest, alerting of emergency medical services is often delayed for several minutes. Therefore, a technological solution to automatically detect cardiac arrests and to instantly trigger an emergency response has the potential to save thousands of lives per year and to greatly improve neurologic recovery and quality of life in survivors. The HEART-SAFE consortium, consisting of two academic centres and three companies in the Netherlands, collaborates to develop and implement a technical solution to reliably detect OHCA based on sensor signals derived from commercially available smartwatches using artificial intelligence. In this manuscript, we describe the rationale, the envisioned solution, as well as a protocol outline of the work packages involved in the development of the technology.
Identifiants
pubmed: 36386769
doi: 10.1016/j.resplu.2022.100324
pii: S2666-5204(22)00124-2
pmc: PMC9664388
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100324Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
Beat Nideröst is CTO of 111b.v., Tom A. Kooy is International Business Developer at Stan b.v., Steve Thijssen is Co-Founder of Wavy Assistant b.v. All three companies are involved in the development of the proposed technology within the HEART-SAFE consortium. Hans van Schuppen reports grants to his institution from the Zoll Foundation and Stryker Emergency Care, both outside the submitted work.
Références
Circulation. 1997 Nov 18;96(10):3308-13
pubmed: 9396421
Ann Emerg Med. 1993 Nov;22(11):1652-8
pubmed: 8214853
NPJ Digit Med. 2019 Jun 19;2:52
pubmed: 31304398
BMJ Open. 2019 Feb 19;9(2):e023627
pubmed: 30782884
Am J Emerg Med. 1985 Mar;3(2):114-9
pubmed: 3970766
Physiol Meas. 2007 Mar;28(3):R1-39
pubmed: 17322588
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
J Clin Monit Comput. 2012 Aug;26(4):255-65
pubmed: 22437884
Am J Emerg Med. 2020 Mar;38(3):526-533
pubmed: 31138516
Sensors (Basel). 2018 Oct 09;18(10):
pubmed: 30304768
Anesth Analg. 2018 Oct;127(4):1085-1091
pubmed: 30096083
Arrhythm Electrophysiol Rev. 2018 Jun;7(2):111-117
pubmed: 29967683
Eur Heart J. 2003 Oct;24(19):1750-5
pubmed: 14522570
Resusc Plus. 2022 Jul 27;11:100277
pubmed: 35935174
Can Assoc Radiol J. 2019 Nov;70(4):344-353
pubmed: 31522841
Resuscitation. 2021 Apr;161:61-79
pubmed: 33773833
Anesth Analg. 2019 Aug;129(2):323
pubmed: 31313667
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):212-7
pubmed: 24610738